De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Bruker Balans Gezondheid
Financiële gezondheid criteriumcontroles 2/6
Bruker heeft een totaal eigen vermogen van $1.8B en een totale schuld van $2.1B, wat de schuld-eigenvermogensverhouding op 116.3% brengt. De totale activa en totale passiva bedragen respectievelijk $5.9B en $4.1B. De EBIT Bruker is $428.2M waardoor de rentedekking 21.6 is. Het heeft contanten en kortetermijnbeleggingen van $182.4M.
Belangrijke informatie
116.3%
Verhouding schuld/eigen vermogen
US$2.12b
Schuld
| Rente dekkingsratio | 21.6x |
| Contant | US$182.40m |
| Aandelen | US$1.82b |
| Totaal verplichtingen | US$4.08b |
| Totaal activa | US$5.90b |
Recente financiële gezondheidsupdates
We Think Bruker (NASDAQ:BRKR) Is Taking Some Risk With Its Debt
Sep 10
Is Bruker (NASDAQ:BRKR) Using Too Much Debt?
Oct 23Bruker (NASDAQ:BRKR) Has A Pretty Healthy Balance Sheet
Jul 11Recent updates
We Think Bruker (NASDAQ:BRKR) Is Taking Some Risk With Its Debt
Sep 10Bruker: Multiple Risks And Declining Returns On Capital Aren't Priced In
Aug 22Is It Too Late To Consider Buying Bruker Corporation (NASDAQ:BRKR)?
Jul 22Bruker Corporation's (NASDAQ:BRKR) Business Is Yet to Catch Up With Its Share Price
Jun 09Bruker: A Confusing Acquisition Spree
May 31Bruker's (NASDAQ:BRKR) Promising Earnings May Rest On Soft Foundations
May 09Bruker Corporation: An Aggressive Acquisition Strategy
Apr 24Bruker Offers Upside With Key Enabling Technologies For Future Bio-Pharma Research
Apr 11Calculating The Fair Value Of Bruker Corporation (NASDAQ:BRKR)
Jan 22There's Reason For Concern Over Bruker Corporation's (NASDAQ:BRKR) Price
Jan 08Should You Be Adding Bruker (NASDAQ:BRKR) To Your Watchlist Today?
Dec 26Is Bruker Corporation (NASDAQ:BRKR) Potentially Undervalued?
Nov 06Is Bruker (NASDAQ:BRKR) Using Too Much Debt?
Oct 23Here's Why Bruker (NASDAQ:BRKR) Has Caught The Eye Of Investors
Sep 25Does This Valuation Of Bruker Corporation (NASDAQ:BRKR) Imply Investors Are Overpaying?
Aug 09Is Now The Time To Look At Buying Bruker Corporation (NASDAQ:BRKR)?
Jul 27Bruker (NASDAQ:BRKR) Has A Pretty Healthy Balance Sheet
Jul 11If EPS Growth Is Important To You, Bruker (NASDAQ:BRKR) Presents An Opportunity
Jun 26Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $2.2B ) BRKR } overtreffen de korte termijn passiva ( $1.3B ).
Langlopende schulden: De kortetermijnactiva van BRKR ( $2.2B ) dekken de langetermijnschulden ( $2.8B ) niet.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 106.3% ) BRKR wordt als hoog beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van BRKR is de afgelopen 5 jaar gestegen van 55.3% naar 116.3%.
Schuldendekking: De schuld van BRKR wordt niet goed gedekt door de operationele kasstroom ( 12.8% ).
Rentedekking: De rentebetalingen op de schuld van BRKR worden goed gedekt door EBIT ( 21.6 x dekking).